查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869738

急性胰臟炎市場規模、佔有率和趨勢分析報告：按藥物類別、分銷管道、地區和細分市場預測（2025-2033 年）

Acute Pancreatitis Market Size, Share & Trends Analysis Report By Drug Class (Analgesics, Antibiotics, Enzyme Inhibitors), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

急性胰臟炎市場摘要

2024年全球急性胰臟炎市場規模估計為33.7億美元，預計2033年將達56億美元。

預計從 2025 年到 2033 年，該市場將以 5.8% 的複合年成長率成長。推動該市場成長的主要因素是人們對胰臟健康的認知不斷提高、文明病的增加以及診斷和治療方法的進步。

微創手術的日益普及、影像技術的進步以及新型酵素替代療法和抗發炎治療方法的研發，正推動市場進一步擴張。此外，持續的臨床研究和不斷完善的醫療基礎設施也進一步增強了急性胰臟炎治療領域的成長前景。

在全球醫療保健實踐不斷發展、生活方式改變和技術進步的推動下，急性胰臟炎市場持續穩定成長。膽結石、過量飲酒、肥胖和代謝紊亂等風險因素的增加，導致急性胰臟炎（AP）——嚴重的消化器官系統性疾病——的發生率上升。根據美國國家醫學圖書館統計，急性胰臟炎每年在全球每10萬人口中約有30-40人患病，是美國胃腸道住院的主要原因。這種情況推動了對先進診斷工具和治療性介入的需求。超音波超音波（EUS）、 電腦斷層掃描和MRI等尖端影像技術正在改善早期診斷和治療，而微創手術和酵素替代療法則正在改善患者康復效果並縮短住院時間。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 全球急性胰臟炎市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析

4. 全球急性胰臟炎市場：藥物類別估算與趨勢分析

  • 2024 年及 2033 年各藥物類別市佔率
  • 藥物類別細分儀表板
  • 按藥物類別分類的市場規模、預測和趨勢分析，2021-2033年
  • 止痛藥
  • 抗生素
  • 酵素抑制劑
  • 其他

5. 全球急性胰臟炎市場：通路業務分析

  • 2024 年及 2033 年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 按分銷管道分類的市場規模、預測和趨勢分析，2021-2033年
  • 醫院藥房
  • 零售藥房
  • 網路藥房

6. 全球急性胰臟炎市場：區域業務分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 按國家/地區分類，2021-2033 年
  • 沙烏地阿拉伯
  • 南非
  • 科威特

第7章 競爭情勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介
    • AbbVie Inc
    • Amgen Inc.
    • Baxter
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Lilly USA, LLC
    • Fresenius SE &Co. KGaA
    • Hikma Pharmaceuticals PLC
    • Johnson &Johnson
    • Merck &Co., Inc.
    • Novartis AG
    • Sanofi
Product Code: GVR-4-68040-785-5

Acute Pancreatitis Market Summary

The global acute pancreatitis market size was estimated at USD 3.37 billion in 2024 and is projected to reach USD 5.60 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033. The market is largely driven by rising awareness of pancreatic health, an increasing prevalence of lifestyle-related disorders, and advances in diagnostic and therapeutic approaches.

Growing adoption of minimally invasive procedures, improved imaging technologies, and the development of novel enzyme replacement and anti-inflammatory treatments are further supporting market expansion. In addition, ongoing clinical research and enhanced healthcare infrastructure continue to strengthen growth prospects for acute pancreatitis management.

The global market for acute pancreatitis is consistently growing, driven by evolving healthcare practices, lifestyle changes, and technological advancements. The increasing prevalence of risk factors such as gallstones, excessive alcohol intake, obesity, and metabolic disorders has contributed to a rising incidence of acute pancreatitis (AP), a serious inflammatory condition of the pancreas. Globally, AP affects approximately 30-40 individuals per 100,000 population annually, according to the National Library of Medicine, and is a major cause of gastrointestinal hospitalizations in the U.S. These dynamics are fueling demand for advanced diagnostic tools and therapeuticinterventions. Cutting-edge imaging technologies, including endoscopic ultrasound (EUS), CT scans, and MRI, enhance early diagnosis and treatment precision, while minimally invasive procedures and enzyme replacement therapies improve recovery outcomes and shorten hospital stays.

Global Acute Pancreatitis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global acute pancreatitis market report based on drug class, distribution channel, and region.

  • Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
  • Analgesics
  • Antibiotics
  • Enzyme Inhibitors
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
    • RoAPAC
  • Latin America
    • Argentina
    • Brazil
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Global Acute Pancreatitis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Global Acute Pancreatitis Market: Drug Class Estimates & Trend Analysis

  • 4.1. Drug Class Market Share, 2024 & 2033
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 4.4. Analgesic
    • 4.4.1. Analgesic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Antibiotics
    • 4.5.1. Antibiotics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Enzyme Inhibitors
    • 4.6.1. Enzyme Inhibitors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Global Acute Pancreatitis Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2033
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Online Pharmacies
    • 5.6.1. Online Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Global Acute Pancreatitis Market: Regional Business Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 6.4. North America
    • 6.4.1. North America Acute Pancreatitis Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1 Key Country Dynamics
      • 6.4.2.2 Type Disease Prevalence
      • 6.4.2.3 Regulatory Framework
      • 6.4.2.4 Reimbursement Framework
      • 6.4.2.5 U.S. Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1 Key Country Dynamics
      • 6.4.3.2 Type Disease Prevalence
      • 6.4.3.3 Regulatory Framework
      • 6.4.3.4 Reimbursement Framework
      • 6.4.3.5 Canada Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1 Key Country Dynamics
      • 6.4.4.2 Type Disease Prevalence
      • 6.4.4.3 Regulatory Framework
      • 6.4.4.4 Reimbursement Framework
      • 6.4.4.5 Mexico Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Acute Pancreatitis Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Type Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Germany Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Type Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. France Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Type Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. Italy Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. UK
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Type Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. UK Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Type Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Type Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Norway Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Type Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Acute Pancreatitis Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Type Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. China Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Japan
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Type Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. Japan Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Type Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Type Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Type Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. Thailand Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. South Korea
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Type Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. South Korea Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.8. RoAPAC
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Type Disease Prevalence
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Reimbursement Framework
      • 6.6.8.5. RoAPAC Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Acute Pancreatitis Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Type Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Argentina Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Brazil
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Type Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. Brazil Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East & Africa
  • 6.9. Middle East & Africa Acute Pancreatitis Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
  • 6.10. Saudi Arabia
      • 6.10.1.1. Key Country Dynamics
      • 6.10.1.2. Type Disease Prevalence
      • 6.10.1.3. Regulatory Framework
      • 6.10.1.4. Reimbursement Framework
      • 6.10.1.5. Saudi Arabia Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. South Africa
      • 6.11.1.1. Key Country Dynamics
      • 6.11.1.2. Type Disease Prevalence
      • 6.11.1.3. Regulatory Framework
      • 6.11.1.4. Reimbursement Framework
      • 6.11.1.5. South Africa Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.12. Kuwait
      • 6.12.1.1. Key Country Dynamics
      • 6.12.1.2. Type Disease Prevalence
      • 6.12.1.3. Regulatory Framework
      • 6.12.1.4. Reimbursement Framework
      • 6.12.1.5. Kuwait Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. AbbVie Inc
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Amgen Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Baxter
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Bayer AG
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Boehringer Ingelheim International GmbH
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Lilly USA, LLC
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Fresenius SE & Co. KGaA
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Hikma Pharmaceuticals PLC
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Johnson & Johnson
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Merck & Co., Inc.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Novartis AG
      • 7.5.11.1. Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. Sanofi
      • 7.5.12.1. Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 4 Global acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 5 Global acute pancreatitis market, by region, 2021-2033 (USD Million)
  • Table 6 North America acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 7 North America acute pancreatitis market, by distributional channel, 2021 - 2033 (USD Million)
  • Table 8 US acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 9 US acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 10 Canada acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 11 Canada acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 12 Mexico acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 13 Mexico acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 14 Asia Pacific acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 15 Asia Pacific acute pancreatitis market, by distributional channel, 2021 - 2033 (USD Million)
  • Table 16 China acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 17 China acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 Japan acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 19 Japan acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20 India acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 21 India acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22 Australia acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 23 Australia acute pancreatitis market, by distributional channel, 2021 - 2033 (USD Million)
  • Table 24 Thailand acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 25 Thailand acute pancreatitis market, by distributional channel, 2021 - 2033 (USD Million)
  • Table 26 South Korea acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 27 South Korea acute pancreatitis market, by distributional channel, 2021 - 2033 (USD Million)
  • Table 28 Latin America acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 29 Latin America acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30 Argentina acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 31 Argentina acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Brazil acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 33 Brazil acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34 Middle East & Africa acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 35 Middle East & Africa acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 36 Saudi Arabia acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 37 Saudi Arabia acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 38 South Africa acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 39 South Africa acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 40 Kuwait acute pancreatitis market, by drug class, 2021 - 2033 (USD Million)
  • Table 41 Kuwait acute pancreatitis market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Global acute pancreatitis market segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Therapeutic Approach and Disease Outlook (USD Million)
  • Fig. 10 Competitive Landscape
  • Fig. 11 Acute Pancreatitis Market Dynamics
  • Fig. 12 Acute Pancreatitis Market Porter's Five Forces Analysis
  • Fig. 13 Acute Pancreatitis Market PESTLE Analysis
  • Fig. 14 Drug Class Market, 2021 - 2033 (USD Million)
  • Fig. 15 Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Antibiotics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Enzyme Inhibitors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Distribution Channel Market, 2021 - 2033 (USD Million)
  • Fig. 20 Hospital Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Retail Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Online Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 North America Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Country Dynamics
  • Fig. 26 U.S. Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Canada Country Dynamics
  • Fig. 28 Canada Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Mexico Country Dynamics
  • Fig. 30 Mexico Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Europe Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Europe Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 UK Country Dynamics
  • Fig. 34 UK Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Spain Country Dynamics
  • Fig. 36 Spain Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Norway Country Dynamics
  • Fig. 38 Norway Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Sweden Country Dynamics
  • Fig. 40 Sweden Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Germany Country Dynamics
  • Fig. 42 Germany Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 France Country Dynamics
  • Fig. 44 France Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Italy Country Dynamics
  • Fig. 46 Italy Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Asia Pacific Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 China Country Dynamics
  • Fig. 49 China Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Japan Country Dynamics
  • Fig. 51 Japan Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 India Country Dynamics
  • Fig. 53 India Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Australia Country Dynamics
  • Fig. 55 Australia Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 South Korea Country Dynamics
  • Fig. 57 South Korea Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand Korea Country Dynamics
  • Fig. 59 Thailand Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Argentina Country Dynamics
  • Fig. 62 Argentina Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Brazil Country Dynamics
  • Fig. 64 Brazil Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Middle East & Africa Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia Country Dynamics
  • Fig. 67 Saudi Arabia Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 South Africa Country Dynamics
  • Fig. 69 South Africa Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Kuwait Country Dynamics
  • Fig. 71 Kuwait Acute Pancreatitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)